MS bears no effect on certain pregnancy complications, stillbirth, or congenital deformationFebruary 5, 2021Multiple Sclerosis
FDA approves intramuscular administration for peginterferon beta-1a in MSFebruary 3, 2021Multiple Sclerosis
Is the EDSS an adequate outcome measure in secondary progressive MS trials?January 29, 2021Multiple Sclerosis
